Home >> Healthcare >> Food & Beverage >>

Global Gastrointestinal Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Published: Aug-2018 | Format: PDF | Global Info Research | Number of pages: 154 | Code: MRS - 353870

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.



Scope of the Report:

This report studies the Gastrointestinal Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastrointestinal Therapeutics market by product type and applications/end industries.

Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.

In terms of geographical regions, the Americas will account for almost 50% of the total market shares and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market’s growth prospects in the next few years.

The global Gastrointestinal Therapeutics market is valued at xx million  in 2017 and is expected to reach xx million  by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastrointestinal Therapeutics.

Europe also play important roles in global market, with market size of xx million  in 2017 and will be xx million  in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

    AbbVie

    Allergan

    Johnson & Johnson

    Takeda

    Novartis

    Pfizer

    Merck

    F. Hoffmann-La Roche

    Eli Lilly

    AstraZeneca

    Procter & Gamble

    Tillotts Pharma

    Shire Pharmaceuticals

    GlaxoSmithKline

    Amgen



Market Segment by Regions, regional analysis covers 

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

    Oral

    Parenteral



Market Segment by Applications, can be divided into

    IBD

    Irritable Bowel Syndrome (IBS)

Table of Contents



1 Gastrointestinal Therapeutics Market Overview

    1.1 Product Overview and Scope of Gastrointestinal Therapeutics

    1.2 Classification of Gastrointestinal Therapeutics by Types

        1.2.1 Global Gastrointestinal Therapeutics Revenue Comparison by Types (2017-2023)

        1.2.2 Global Gastrointestinal Therapeutics Revenue Market Share by Types in 2017

        1.2.3 Oral

        1.2.4 Parenteral

    1.3 Global Gastrointestinal Therapeutics Market by Application

        1.3.1 Global Gastrointestinal Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

        1.3.2 IBD

        1.3.3 Irritable Bowel Syndrome (IBS)

    1.4 Global Gastrointestinal Therapeutics Market by Regions

        1.4.1 Global Gastrointestinal Therapeutics Market Size (Million ) Comparison by Regions (2013-2023)

        1.4.1 North America (USA, Canada and Mexico) Gastrointestinal Therapeutics Status and Prospect (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastrointestinal Therapeutics Status and Prospect (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)

        1.4.4 South America (Brazil, Argentina, Colombia) Gastrointestinal Therapeutics Status and Prospect (2013-2023)

        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastrointestinal Therapeutics Status and Prospect (2013-2023)

    1.5 Global Market Size of Gastrointestinal Therapeutics (2013-2023)

2 Manufacturers Profiles

    2.1 AbbVie

        2.1.1 Business Overview

        2.1.2 Gastrointestinal Therapeutics Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 AbbVie Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.2 Allergan

        2.2.1 Business Overview

        2.2.2 Gastrointestinal Therapeutics Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 Allergan Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Johnson & Johnson

        2.3.1 Business Overview

        2.3.2 Gastrointestinal Therapeutics Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Johnson & Johnson Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Takeda

        2.4.1 Business Overview

        2.4.2 Gastrointestinal Therapeutics Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Takeda Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Novartis

        2.5.1 Business Overview

        2.5.2 Gastrointestinal Therapeutics Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Novartis Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.6 Pfizer

        2.6.1 Business Overview

        2.6.2 Gastrointestinal Therapeutics Type and Applications

            2.6.2.1 Product A

            2.6.2.2 Product B

        2.6.3 Pfizer Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.7 Merck

        2.7.1 Business Overview

        2.7.2 Gastrointestinal Therapeutics Type and Applications

            2.7.2.1 Product A

            2.7.2.2 Product B

        2.7.3 Merck Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.8 F. Hoffmann-La Roche

        2.8.1 Business Overview

        2.8.2 Gastrointestinal Therapeutics Type and Applications

            2.8.2.1 Product A

            2.8.2.2 Product B

        2.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.9 Eli Lilly

        2.9.1 Business Overview

        2.9.2 Gastrointestinal Therapeutics Type and Applications

            2.9.2.1 Product A

            2.9.2.2 Product B

        2.9.3 Eli Lilly Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.10 AstraZeneca

        2.10.1 Business Overview

        2.10.2 Gastrointestinal Therapeutics Type and Applications

            2.10.2.1 Product A

            2.10.2.2 Product B

        2.10.3 AstraZeneca Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.11 Procter & Gamble

        2.11.1 Business Overview

        2.11.2 Gastrointestinal Therapeutics Type and Applications

            2.11.2.1 Product A

            2.11.2.2 Product B

        2.11.3 Procter & Gamble Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.12 Tillotts Pharma

        2.12.1 Business Overview

        2.12.2 Gastrointestinal Therapeutics Type and Applications

            2.12.2.1 Product A

            2.12.2.2 Product B

        2.12.3 Tillotts Pharma Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.13 Shire Pharmaceuticals

        2.13.1 Business Overview

        2.13.2 Gastrointestinal Therapeutics Type and Applications

            2.13.2.1 Product A

            2.13.2.2 Product B

        2.13.3 Shire Pharmaceuticals Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.14 GlaxoSmithKline

        2.14.1 Business Overview

        2.14.2 Gastrointestinal Therapeutics Type and Applications

            2.14.2.1 Product A

            2.14.2.2 Product B

        2.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

    2.15 Amgen

        2.15.1 Business Overview

        2.15.2 Gastrointestinal Therapeutics Type and Applications

            2.15.2.1 Product A

            2.15.2.2 Product B

        2.15.3 Amgen Gastrointestinal Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Gastrointestinal Therapeutics Market Competition, by Players

    3.1 Global Gastrointestinal Therapeutics Revenue and Share by Players (2013-2018)

    3.2 Market Concentration Rate

        3.2.1 Top 5 Gastrointestinal Therapeutics Players Market Share

        3.2.2 Top 10 Gastrointestinal Therapeutics Players Market Share

    3.3 Market Competition Trend

4 Global Gastrointestinal Therapeutics Market Size by Regions

    4.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Regions

    4.2 North America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    4.3 Europe Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    4.4 Asia-Pacific Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    4.5 South America Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    4.6 Middle East and Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Gastrointestinal Therapeutics Revenue by Countries

    5.1 North America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)

    5.2 USA Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    5.3 Canada Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    5.4 Mexico Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Gastrointestinal Therapeutics Revenue by Countries

    6.1 Europe Gastrointestinal Therapeutics Revenue by Countries (2013-2018)

    6.2 Germany Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    6.3 UK Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    6.4 France Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    6.5 Russia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    6.6 Italy Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Gastrointestinal Therapeutics Revenue by Countries

    7.1 Asia-Pacific Gastrointestinal Therapeutics Revenue by Countries (2013-2018)

    7.2 China Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    7.3 Japan Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    7.4 Korea Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    7.5 India Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    7.6 Southeast Asia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Gastrointestinal Therapeutics Revenue by Countries

    8.1 South America Gastrointestinal Therapeutics Revenue by Countries (2013-2018)

    8.2 Brazil Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    8.3 Argentina Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    8.4 Colombia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Gastrointestinal Therapeutics by Countries

    9.1 Middle East and Africa Gastrointestinal Therapeutics Revenue by Countries (2013-2018)

    9.2 Saudi Arabia Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    9.3 UAE Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    9.4 Egypt Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    9.5 Nigeria Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

    9.6 South Africa Gastrointestinal Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Gastrointestinal Therapeutics Market Segment by Type

    10.1 Global Gastrointestinal Therapeutics Revenue and Market Share by Type (2013-2018)

    10.2 Global Gastrointestinal Therapeutics Market Forecast by Type (2018-2023)

    10.3 Oral Revenue Growth Rate (2013-2023)

    10.4 Parenteral Revenue Growth Rate (2013-2023)

11 Global Gastrointestinal Therapeutics Market Segment by Application

    11.1 Global Gastrointestinal Therapeutics Revenue Market Share by Application (2013-2018)

    11.2 Gastrointestinal Therapeutics Market Forecast by Application (2018-2023)

    11.3 IBD Revenue Growth (2013-2018)

    11.4 Irritable Bowel Syndrome (IBS) Revenue Growth (2013-2018)

12 Global Gastrointestinal Therapeutics Market Size Forecast (2018-2023)

    12.1 Global Gastrointestinal Therapeutics Market Size Forecast (2018-2023)

    12.2 Global Gastrointestinal Therapeutics Market Forecast by Regions (2018-2023)

    12.3 North America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)

    12.4 Europe Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)

    12.5 Asia-Pacific Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)

    12.6 South America Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)

    12.7 Middle East and Africa Gastrointestinal Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

    14.1 Methodology

    14.2 Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3480 View Pricing